98 related articles for article (PubMed ID: 27329088)
41. Effects of montelukast and budesonide on airway responses and airway inflammation in asthma.
Leigh R; Vethanayagam D; Yoshida M; Watson RM; Rerecich T; Inman MD; O'Byrne PM
Am J Respir Crit Care Med; 2002 Nov; 166(9):1212-7. PubMed ID: 12403690
[TBL] [Abstract][Full Text] [Related]
42. [Effect of okam on inflammation and remodeling of airway of mice with ovalbumin induced asthma].
Qu ZH; Xie N; Che SY; Lin RJ; Hu SJ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Apr; 21(4):230-3. PubMed ID: 19374792
[TBL] [Abstract][Full Text] [Related]
43. Inhaled fluticasone and salmeterol suppress eosinophilic airway inflammation in chronic obstructive pulmonary disease: relations with lung function and bronchodilator reversibility.
Perng DW; Wu CC; Su KC; Lee YC; Perng RP; Tao CW
Lung; 2006; 184(4):217-22. PubMed ID: 17006748
[TBL] [Abstract][Full Text] [Related]
44. Antitussive activity of Althaea officinalis L. polysaccharide rhamnogalacturonan and its changes in guinea pigs with ovalbumine-induced airways inflammation.
Sutovska M; Capek P; Franova S; Joskova M; Sutovsky J; Marcinek J; Kalman M
Bratisl Lek Listy; 2011; 112(12):670-5. PubMed ID: 22372330
[TBL] [Abstract][Full Text] [Related]
45. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
Yates DH; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
[TBL] [Abstract][Full Text] [Related]
46. [Increased dosage of inhaled corticosteroids or addition of salmeterol in symptomatic asthma].
Jébrak G
Presse Med; 2000 Sep; 29(27):1512-3. PubMed ID: 11045121
[No Abstract] [Full Text] [Related]
47. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy.
Price D; Wirén A; Kuna P
Allergy; 2007 Oct; 62(10):1189-98. PubMed ID: 17845590
[TBL] [Abstract][Full Text] [Related]
48. Combined fluticasone propionate and salmeterol reduces RSV infection more effectively than either of them alone in allergen-sensitized mice.
Singam R; Jena PK; Behera S; Hellermann GR; Lockey RF; Ledford D; Mohapatra SS
Virol J; 2006 May; 3():32. PubMed ID: 16719922
[TBL] [Abstract][Full Text] [Related]
49. Sites of allergic airway smooth muscle remodeling and hyperresponsiveness are not associated in the rat.
Siddiqui S; Jo T; Tamaoka M; Shalaby KH; Ghezzo H; Bernabeu M; Martin JG
J Appl Physiol (1985); 2010 Oct; 109(4):1170-8. PubMed ID: 20651225
[TBL] [Abstract][Full Text] [Related]
50. Fluticasone versus salmeterol/low-dose fluticasone for long-term asthma control.
Heyneman CA; Crafts R; Holland J; Arnold AD
Ann Pharmacother; 2002 Dec; 36(12):1944-9. PubMed ID: 12452759
[TBL] [Abstract][Full Text] [Related]
51. [RORγt expression in the pulmonary tissue of asthmatic mice and the inhibitory effects of budesonide].
Bian FF; Wang J; Lu M; Wu Y
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Aug; 14(8):628-31. PubMed ID: 22898287
[TBL] [Abstract][Full Text] [Related]
52. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T
Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018
[TBL] [Abstract][Full Text] [Related]
53. Effectiveness of combination therapies in asthma: an observational study.
Suissa S; Dell'Aniello S; Ernst P
Pulm Pharmacol Ther; 2009 Jun; 22(3):194-8. PubMed ID: 19063985
[TBL] [Abstract][Full Text] [Related]
54. Btk Inhibitor RN983 Delivered by Dry Powder Nose-only Aerosol Inhalation Inhibits Bronchoconstriction and Pulmonary Inflammation in the Ovalbumin Allergic Mouse Model of Asthma.
Phillips JE; Renteria L; Burns L; Harris P; Peng R; Bauer CM; Laine D; Stevenson CS
J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):233-41. PubMed ID: 27111445
[TBL] [Abstract][Full Text] [Related]
55. Comparable effect of a leukotriene receptor antagonist and long-acting beta₂-adrenergic agonist in cough variant asthma.
Tamaoki J; Yokohori N; Tagaya E; Kirishi S; Miyamoto Y; Ochiai K; Kondo M; Nagai A
Allergy Asthma Proc; 2010; 31(5):78-84. PubMed ID: 20929598
[TBL] [Abstract][Full Text] [Related]
56. Comparison of the effects of budesonide/formoterol maintenance and reliever therapy with fluticasone/salmeterol fixed-dose treatment on airway inflammation and small airway impairment in patients who need to step-up from inhaled corticosteroid monotherapy.
Hozawa S; Terada M; Hozawa M
Pulm Pharmacol Ther; 2014 Apr; 27(2):190-6. PubMed ID: 24388868
[TBL] [Abstract][Full Text] [Related]
57. Effects of budesonide/formoterol combination therapy versus budesonide alone on airway dimensions in asthma.
Hoshino M; Ohtawa J
Respirology; 2012 May; 17(4):639-46. PubMed ID: 22248352
[TBL] [Abstract][Full Text] [Related]
58. Differences in the pharmacodynamics of budesonide/formoterol and salmeterol/fluticasone reflect differences in their therapeutic usefulness in asthma.
Lindmark B
Ther Adv Respir Dis; 2008 Oct; 2(5):279-99. PubMed ID: 19124378
[TBL] [Abstract][Full Text] [Related]
59. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
[TBL] [Abstract][Full Text] [Related]
60. The long-term administration of Orai 1 antagonist possesses antitussive, bronchodilatory and anti-inflammatory effects in experimental asthma model.
Sutovská M; Kocmálová M; Adamkov M; Výbohová D; Mikolka P; Mokrá D; Hatok J; Antošová M; Fraňová S
Gen Physiol Biophys; 2013 Jun; 32(2):251-9. PubMed ID: 23682025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
